Cargando…
Paliperidone induced sinus tachycardia in a patient with first episode of psychosis (FEP)
INTRODUCTION: This is a presentation of the FEP of a 23 y.o. patient. The patient had a Duration of Untreated Psychosis (DUP) of 6 months and Duration of Untreated Illness (DUI) of six years. The therapeutic response and the adverse effects of Paliperidone are being described. OBJECTIVES: To investi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480226/ http://dx.doi.org/10.1192/j.eurpsy.2021.2056 |
_version_ | 1784791004258238464 |
---|---|
author | Sarafopoulos, A. Antoniadis, D. Karpouza, V. |
author_facet | Sarafopoulos, A. Antoniadis, D. Karpouza, V. |
author_sort | Sarafopoulos, A. |
collection | PubMed |
description | INTRODUCTION: This is a presentation of the FEP of a 23 y.o. patient. The patient had a Duration of Untreated Psychosis (DUP) of 6 months and Duration of Untreated Illness (DUI) of six years. The therapeutic response and the adverse effects of Paliperidone are being described. OBJECTIVES: To investigate the tolerance of Paliperidone in a patient with FEP. METHODS: The patient was assessed regularly by the psychiatric team consisting of a CT doctor and one General Adult Consultant. Appropriate psychological assessments and investigations took place. RESULTS: Upon admission the patient appeared guarded. She also presented with weight loss and dehydration. Initial PANSS score was 173, positive subscale 41. The patient was initially treated with monotherapy 6mg of Paliperidone. However, the heart rate was around 100 bpm culminating as high as 156 bpm. The ECG indicated sinus tachycardia. The patient presented with serious EPSs and diarrhea. Simpson-Angus Scale score 10. Metoprolol 25mg was prescribed twice a day. The clinical team proceeded in cross titration replacing Paliperidone with Olanzapine. A brain CT scan was also performed, unremarkable. After 10 days of therapy the PANSS score reduced to 102, positive subscale 21. CONCLUSIONS: Initial sinus tachycardia is a common adverse effect of Paliperidone. However in this case the tachycardia was refractory in time even after the 7th day, making an alternative SGA trial necessary. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9480226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94802262022-09-29 Paliperidone induced sinus tachycardia in a patient with first episode of psychosis (FEP) Sarafopoulos, A. Antoniadis, D. Karpouza, V. Eur Psychiatry Abstract INTRODUCTION: This is a presentation of the FEP of a 23 y.o. patient. The patient had a Duration of Untreated Psychosis (DUP) of 6 months and Duration of Untreated Illness (DUI) of six years. The therapeutic response and the adverse effects of Paliperidone are being described. OBJECTIVES: To investigate the tolerance of Paliperidone in a patient with FEP. METHODS: The patient was assessed regularly by the psychiatric team consisting of a CT doctor and one General Adult Consultant. Appropriate psychological assessments and investigations took place. RESULTS: Upon admission the patient appeared guarded. She also presented with weight loss and dehydration. Initial PANSS score was 173, positive subscale 41. The patient was initially treated with monotherapy 6mg of Paliperidone. However, the heart rate was around 100 bpm culminating as high as 156 bpm. The ECG indicated sinus tachycardia. The patient presented with serious EPSs and diarrhea. Simpson-Angus Scale score 10. Metoprolol 25mg was prescribed twice a day. The clinical team proceeded in cross titration replacing Paliperidone with Olanzapine. A brain CT scan was also performed, unremarkable. After 10 days of therapy the PANSS score reduced to 102, positive subscale 21. CONCLUSIONS: Initial sinus tachycardia is a common adverse effect of Paliperidone. However in this case the tachycardia was refractory in time even after the 7th day, making an alternative SGA trial necessary. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9480226/ http://dx.doi.org/10.1192/j.eurpsy.2021.2056 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Sarafopoulos, A. Antoniadis, D. Karpouza, V. Paliperidone induced sinus tachycardia in a patient with first episode of psychosis (FEP) |
title | Paliperidone induced sinus tachycardia in a patient with first episode of psychosis (FEP) |
title_full | Paliperidone induced sinus tachycardia in a patient with first episode of psychosis (FEP) |
title_fullStr | Paliperidone induced sinus tachycardia in a patient with first episode of psychosis (FEP) |
title_full_unstemmed | Paliperidone induced sinus tachycardia in a patient with first episode of psychosis (FEP) |
title_short | Paliperidone induced sinus tachycardia in a patient with first episode of psychosis (FEP) |
title_sort | paliperidone induced sinus tachycardia in a patient with first episode of psychosis (fep) |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480226/ http://dx.doi.org/10.1192/j.eurpsy.2021.2056 |
work_keys_str_mv | AT sarafopoulosa paliperidoneinducedsinustachycardiainapatientwithfirstepisodeofpsychosisfep AT antoniadisd paliperidoneinducedsinustachycardiainapatientwithfirstepisodeofpsychosisfep AT karpouzav paliperidoneinducedsinustachycardiainapatientwithfirstepisodeofpsychosisfep |